Cargando…
Functional Outcome Measures of Recombinant Tissue Plasminogen Activator–Treated Stroke Patients in the Telestroke Technology
The efficiency of telestroke programs in improving the rates of recombinant tissue plasminogen activator (rtPA) in stroke patients has been reported. Previous studies have reported favorable treatment outcomes with the use of telestroke programs to improve the use of rtPA, but functional outcomes ar...
Autores principales: | Gainey, Jordan, Brecthtel, Leanne, Blum, Brice, Keels, Aaliyah, Madeline, Lee, Lowther, Ervin, Nathaniel, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144501/ https://www.ncbi.nlm.nih.gov/pubmed/30245570 http://dx.doi.org/10.1177/1179069518793412 |
Ejemplares similares
-
Stroke and dyslipidemia: clinical risk factors in the telestroke versus non-telestroke
por: Gainey, Jordan, et al.
Publicado: (2018) -
Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke
por: Bruce, Nhu T., et al.
Publicado: (2011) -
The Role of Hospitalists in the Acute Care of Stroke Patients
por: Amin, Alpesh, et al.
Publicado: (2010) -
Update on Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
por: Abcede, Hermelinda G., et al.
Publicado: (2010) -
Principled Versus Statistical Thinking in Diagnosis and Treatment of Stroke
por: Helgason, Cathy M., et al.
Publicado: (2010)